The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Focus on personalized treatment of type 2 diabetes and cardiovascular disease

The European Research Council makes a large investment in diabetes research. A project led by Professor Paul Franks at Lund University Diabetes Centre is to develop methods that can be used in the design of preventive treatment for type 2 diabetes and cardiovascular disease.

- Through this project we will use functional genomics and epidemiology to identify novel molecular mechanisms that underlie the protective effects if diet and exercise on type 2 diabetes adn cardiovascular disease. We will then utilize that knowledge to isolate biomarkers that can be used to optimize the design of lifestylge interventions by tailoring them to the biological characteristics of the patient. The efficacy of this approach will be tested in clincila trials, says Paul Franks professor of Professor of Genetic Epidemiology.

European Research Council (ERC) mission is to promote reserach of the highest quality through comprehensive, long-term financing. ERC Consolidator Grants are very prestigious research grant of approximately EUR 2 million over five years.